Balchem Corporation
NASDAQ:BCPCChemicals - Specialty
+$1.03 today
- Market cap
- $5.36B
- Beta
- 0.83
- P/E (TTM)
- 33.8
- EPS (TTM)
- $4.90
- Dividend yield
- 0.58%
Volume 0.21M
Average 0.21M
BCPC Operating Expenses
Total costs of running the business that are not directly tied to producing goods or services sold.
Balchem CorporationNASDAQ: BCPC
Operating Expenses · Q3 FY2026 · quarter ended Sep 2026
Operating expenses grows in line with its trailing trend
Q3 FY2026 operating expenses of $43.28M rose 5.9% year over year, ahead of the +5.3% change in trailing-twelve-month operating expenses. Sequentially, it fell 2.7% from the prior quarter. Over 3 fiscal years it compounded at +4.0% a year.
Context
- Operating expenses amounted to 14.7% of revenue in FY2025, down 1.4 pp from a year earlier.
- Operating expenses increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +5.9% holds above the trailing-twelve-month pace of +5.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Operating Expenses history
USD · from the income statement
- Latest · FY2025
- 152.3M USD
- Year-over-year change
- -0.6%
- 4-year CAGR
- +7.1%
| Period | Period end | Operating Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 152.3M | -0.6% |
| FY2024 | 2024-12-31 | 153.3M | +7.3% |
| FY2023 | 2023-12-31 | 142.86M | +5.6% |
| FY2022 | 2022-12-31 | 135.27M | +16.9% |
| FY2021 | 2021-12-31 | 115.67M | — |
Operating Expenses vs competitors
How BCPC compares with its peers on the latest reported figures
- BCPC's LTM Sep 2026 operating expenses of $167.03M is the 10th highest of the 11 companies compared; the peer median is $580.82M.
- Its year-over-year change of +5.3% is the 3rd highest of 11, against a peer median of +2.9%.
- Operating expenses amounts to 15.1% of revenue for BCPC, versus a peer median of 20.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $2.97B | -32.9% | -17.3% | 29.7% | |
| LTM Jun 2026 | $928M | +3.7% | -2.1% | 10.5% | |
| LTM Jun 2026 | $851M | -4.8% | +2.6% | 11.8% | |
| LTM Sep 2026 | $764.8M | -3.3% | +10.2% | 22.4% | |
| LTM Aug 2026 | $755.64M | +4.5% | +3.0% | 21.3% | |
| LTM Jun 2026 | $406M | +2.5% | +38.6% | 22.0% | |
| LTM Jun 2026 | $356.2M | +3.2% | -5.6% | 19.3% | |
| LTM Jun 2026 | $350.86M | +9.4% | +4.3% | 20.6% | |
| LTM Mar 2026 | $202.37M | +1.8% | -3.0% | 8.6% | |
| LTM Sep 2026 | $167.03M | +5.3% | +4.0% | 15.1% | |
| LTM Sep 2026 | $134.19M | +15.1% | +12.2% | 11.8% | |
| Peer median (excluding BCPC) | $580.82M | +2.9% | +2.8% | 20.0% | |
Competitors are the stored peer set for BCPC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 799.02M | 942.36M | 922.44M | 953.68M | 1.04B |
| Cost of Revenue | 555.85M | 661.91M | 620.38M | 617.48M | 666.53M |
| Gross Profit | 243.17M | 280.45M | 302.06M | 336.21M | 370.63M |
| Gross Margin | 30.4% | 29.8% | 32.7% | 35.3% | 35.7% |
| Research & Development | 13.52M | 12.19M | 15.05M | 16.79M | 18.51M |
| Selling, General & Admin | 102.15M | 123.07M | 130.13M | 136.5M | 142.8M |
| Operating Expenses | 115.67M | 135.27M | 142.86M | 153.3M | 152.3M |
| Depreciation & Amortization | 48.88M | 51.85M | 54.94M | 47.97M | 45.69M |
| EBITDA | 176.57M | 195.87M | 214.81M | 230.95M | 254.94M |
| EBITDA Margin | 22.1% | 20.8% | 23.3% | 24.2% | 24.6% |
| Operating Income | 127.5M | 145.19M | 159.19M | 182.91M | 218.33M |
| Operating Margin | 16.0% | 15.4% | 17.3% | 19.2% | 21.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 2.46M | 10.27M | 22.61M | 16.53M | 10.22M |
| Other Income / Expenses | (2.27M) | (11.44M) | (21.93M) | (16.46M) | (19.3M) |
| Income Before Tax | 125.23M | 133.75M | 137.26M | 166.45M | 199.03M |
| Pre-Tax Margin | 15.7% | 14.2% | 14.9% | 17.5% | 19.2% |
| Income Tax Expense | 29.13M | 28.38M | 28.72M | 37.98M | 44.19M |
| Net Income | 96.1M | 105.37M | 108.54M | 128.48M | 154.85M |
| Net Margin | 12.0% | 11.2% | 11.8% | 13.5% | 14.9% |
| EPS (Basic) | 2.98 | 3.29 | 3.38 | 3.97 | 4.80 |
| EPS (Diluted) | 2.94 | 3.25 | 3.35 | 3.93 | 4.75 |
| Weighted Avg Shares | 32.22M | 32.02M | 32.11M | 32.33M | 32.6M |
| Weighted Avg Shares (Diluted) | 32.67M | 32.39M | 32.45M | 32.72M | 32.6M |
Balchem Corporation
NASDAQ:BCPC
Intrinsic Alpha fair value
Locked
Current Price
$168.73
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.